AEON Biopharma, Inc. - AEON
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 03, 2026 | CHIEF FINANCIAL OFFICER | A | A | 754,717.0 | 0.0 | 0.0 | 754,717.0 | View | |
| Mar 11, 2026 | CHIEF MEDICAL OFFICER | A | A | 1,316,872.0 | 0.0 | 0.0 | 2,183,436.0 | View | |
| Mar 11, 2026 | CHIEF MEDICAL OFFICER | A | A | 862,500.0 | 0.0 | 0.0 | 866,564.0 | View | |
| Mar 05, 2026 | PRINCIPAL ACCOUNTING OFFICER | A | A | 925,925.0 | 0.0 | 0.0 | 1,501,176.0 | View | |
| Mar 05, 2026 | PRINCIPAL ACCOUNTING OFFICER | A | A | 575,000.0 | 0.0 | 0.0 | 575,251.0 | View | |
| Mar 05, 2026 | CLO, CSO, and Corp Secretary | A | A | 1,316,872.0 | 0.0 | 0.0 | 2,183,005.0 | View | |
| Mar 05, 2026 | CLO, CSO, and Corp Secretary | A | A | 862,500.0 | 0.0 | 0.0 | 866,133.0 | View | |
| Feb 19, 2026 | PRESIDENT & CEO | A | A | 3,000,000.0 | 0.0 | 0.0 | 3,177,103.0 | View |